selenocysteine and Osteogenic Sarcoma

selenocysteine has been researched along with Osteogenic Sarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, X; Meng, FB; Wang, W; Wang, ZX; Zhou, DS	1
Guo, HH; Huang, G; Li, JC; Shen, JN; Xu, MH; Yong, BC	1

Other Studies

2 other study(ies) available for selenocysteine and Osteogenic Sarcoma

Article	Year
Selenocysteine inhibits human osteosarcoma cells growth through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation. Cell biology international, 2018, Volume: 42, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Mice, Nude; Mitochondria; Osteosarcoma; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Selenocysteine; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2018
Analysis of Selenium Levels in Osteosarcoma Patients and the Effects of Se-Methylselenocysteine on Osteosarcoma Cells In Vitro. Nutrition and cancer, 2015, Volume: 67, Issue:5 Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Child; Drug Evaluation, Preclinical; Female; Genes, bcl-2; Humans; Male; Middle Aged; Osteosarcoma; Selenium; Selenocysteine; Young Adult	2015

Article

Year

Selenocysteine inhibits human osteosarcoma cells growth through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation.

Cell biology international, 2018, Volume: 42, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Mice, Nude; Mitochondria; Osteosarcoma; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Selenocysteine; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018

Analysis of Selenium Levels in Osteosarcoma Patients and the Effects of Se-Methylselenocysteine on Osteosarcoma Cells In Vitro.

Nutrition and cancer, 2015, Volume: 67, Issue:5

Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Child; Drug Evaluation, Preclinical; Female; Genes, bcl-2; Humans; Male; Middle Aged; Osteosarcoma; Selenium; Selenocysteine; Young Adult

2015